CG Oncology, Inc. Common stock (CGON) stock news · rev $4.0M
CG Oncology, Inc. Common stock (CGON) is a biotechnology company listed on US.
This CGON news page leads with what CG Oncology, Inc. Common stock filed — not a scraped headline mill.
No cached 8-K sentence for CGON yet. We will not pad this page with generic market recap.
Latest reported CGON revenue for 2025-12-31 was $4.0M. Net income was -$161.0M. Revenue was up 254.7% from 2024-12-31 to 2025-12-31. CGON currently screens at market cap $4.74B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CGON stock page; for the tape open the quote page.
CGON stock news FAQ
What are CGON's latest revenue and net income?
Latest cached CG Oncology, Inc. Common stock (CGON) revenue for Dec 31, 2025 was $4.0M. Net income was -$161.0M. Statements: https://lician.com/financials/cgon
How did CGON revenue change from the prior cached period?
Cached CG Oncology, Inc. Common stock (CGON) revenue was up 254.7% from $1.1M (Dec 31, 2024) to $4.0M (Dec 31, 2025). Statements: https://lician.com/financials/cgon
What is CGON's market cap?
CG Oncology, Inc. Common stock (CGON) market cap is $4.74B on the latest cached fundamentals snapshot.
What kind of company is CGON?
CG Oncology, Inc. Common stock (CGON) is a biotechnology company listed on US.
Where is CGON stock news listed?
Cached stock news for CG Oncology, Inc. Common stock (CGON) is listed at https://lician.com/news/cgon. Filings: https://lician.com/sec/cgon
Not investment advice.